BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Couvert P, Carrié A, Pariès J, Vaysse J, Miroglio A, Kerjean A, Nahon P, Chelly J, Trinchet JC, Beaugrand M, Ganne-Carrié N. Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma. World J Gastroenterol 2008; 14(35): 5419-5427 [PMID: 18803353 DOI: 10.3748/wjg.14.5419]
URL: https://www.wjgnet.com/1007-9327/full/v14/i35/5419.htm
Number Citing Articles
1
Yuhan Zhu, Lin Chen, Binyu Song, Zhiwei Cui, Guo Chen, Zhou Yu, Baoqiang Song. Insulin-like Growth Factor-2 (IGF-2) in FibrosisBiomolecules 2022; 12(11): 1557 doi: 10.3390/biom12111557
2
Kelly McDaniel, Chad Hall, Keisaku Sato, Terry Lairmore, Marco Marzioni, Shannon Glaser, Fanyin Meng, Gianfranco Alpini. Lin28 and let-7: roles and regulation in liver diseasesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(10): G757 doi: 10.1152/ajpgi.00080.2016
3
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)International Journal of Oncology 2012; 41(6): 1919 doi: 10.3892/ijo.2012.1666
4
Callum Livingstone. IGF2 and cancerEndocrine-Related Cancer 2013; 20(6): R321 doi: 10.1530/ERC-13-0231
5
Mónica Enguita-Germán, Puri Fortes. Targeting the insulin-like growth factor pathway in hepatocellular carcinomaWorld Journal of Hepatology 2014; 6(10): 716-737 doi: 10.4254/wjh.v6.i10.716
6
Philippe Couvert, Alain Carrié, Sophie Tezenas du Montcel, Jenny Vaysse, Angela Sutton, Nathalie Barget, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne, Philippe Giral, Jamel Chelly. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2012; 36(4): 345 doi: 10.1016/j.clinre.2012.06.013
7
Takeshi Tomoda, Kazuhiro Nouso, Akiko Sakai, Mamoru Ouchida, Sayo Kobayashi, Koji Miyahara, Hideki Onishi, Shinichiro Nakamura, Kazuhide Yamamoto, Kenji Shimizu. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control studyJournal of Gastroenterology and Hepatology 2012; 27(4): 797 doi: 10.1111/j.1440-1746.2011.06948.x
8
Danira Ashraf Habashy, Hend Mohamed El Tayebi, Injie Omar Fawzy, Karim Adel Hosny, Gamal Esmat, Ahmed Ihab Abdelaziz. Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinomaWorld Journal of Hepatology 2016; 8(23): 976-984 doi: 10.4254/wjh.v8.i23.976
9
Yasushi Adachi, Masanori Nojima, Mitsuru Mori, Ryogo Himori, Toshiyuki Kubo, Noriyuki Akutsu, Yingsong Lin, Youichi Kurozawa, Kenji Wakai, Akiko Tamakoshi. Insulin-Like Growth Factor 2 and Incidence of Liver Cancer in a Nested Case–Control StudyCancer Epidemiology, Biomarkers & Prevention 2021; 30(11): 2130 doi: 10.1158/1055-9965.EPI-21-0481
10
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesisJournal of Hepatology 2009; 51(4): 810 doi: 10.1016/j.jhep.2009.05.008
11
Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adamek, Anna Gozdzicka-Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesisMutation Research/Reviews in Mutation Research 2017; 772: 78 doi: 10.1016/j.mrrev.2016.08.007
12
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver DiseasesInternational Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
13
C. Nelson Hayes, Peiyi Zhang, Yizhou Zhang, Kazuaki Chayama. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus InfectionViruses 2018; 10(10): 531 doi: 10.3390/v10100531
14
Hubert E. Blum. Viral Hepatitis2013; : 353 doi: 10.1002/9781118637272.ch24
15
Jing Qian, Dengfu Yao, Zhizhen Dong, Wei Wu, Liwei Qiu, Ninghua Yao, Shanshan Li, Yinzhu Bian, Zhiwei Wang, Gongsheng Shi. Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2010; 134(5): 799 doi: 10.1309/AJCPTFDSE2V3LCZP
16
N A Wijetunga, M Pascual, J Tozour, F Delahaye, M Alani, M Adeyeye, A W Wolkoff, A Verma, J M Greally. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targetsOncogene 2017; 36(14): 2030 doi: 10.1038/onc.2016.340
17
Chang Zhang, Lei Shen, Wei Yuan, Yuguo Liu, Ruochen Guo, Yangjun Luo, Zheng Zhan, Zhiqin Xie, Guohao Wu, Wenwu Wu, Ying Feng. Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in miceCommunications Biology 2020; 3(1) doi: 10.1038/s42003-020-0893-5
18
Sonja M. Kessler, Stephan Laggai, Elien Van Wonterg, Katja Gemperlein, Rolf Müller, Johannes Haybaeck, Roosmarijn E. Vandenbroucke, Manfred Ogris, Claude Libert, Alexandra K. Kiemer. Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet FormationFrontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00147
19
Lysann Tietze, Sonja M. Kessler. The Good, the Bad, the Question–H19 in Hepatocellular CarcinomaCancers 2020; 12(5): 1261 doi: 10.3390/cancers12051261
20
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728